LABS vs. IHR, MXF, PHP, AGR, THRL, HWG, MLI, WHR, RDI, and PCTN
Should you be buying Life Science REIT stock or one of its competitors? The main competitors of Life Science REIT include Impact Healthcare REIT (IHR), Medicx Fund (MXF), Primary Health Properties (PHP), Assura (AGR), Target Healthcare REIT (THRL), Harworth Group (HWG), Industrials REIT (MLI), Warehouse REIT (WHR), Rdi Reit (RDI), and Picton Property Income (PCTN). These companies are all part of the "real estate" sector.
Life Science REIT vs. Its Competitors
Impact Healthcare REIT (LON:IHR) and Life Science REIT (LON:LABS) are both small-cap real estate companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk, analyst recommendations and media sentiment.
Impact Healthcare REIT has a beta of 0.37, indicating that its stock price is 63% less volatile than the S&P 500. Comparatively, Life Science REIT has a beta of 0.08, indicating that its stock price is 92% less volatile than the S&P 500.
Impact Healthcare REIT has higher revenue and earnings than Life Science REIT. Life Science REIT is trading at a lower price-to-earnings ratio than Impact Healthcare REIT, indicating that it is currently the more affordable of the two stocks.
Impact Healthcare REIT has a net margin of 88.90% compared to Life Science REIT's net margin of -198.99%. Impact Healthcare REIT's return on equity of 9.90% beat Life Science REIT's return on equity.
In the previous week, Life Science REIT had 1 more articles in the media than Impact Healthcare REIT. MarketBeat recorded 1 mentions for Life Science REIT and 0 mentions for Impact Healthcare REIT. Impact Healthcare REIT's average media sentiment score of 0.00 equaled Life Science REIT'saverage media sentiment score.
59.5% of Impact Healthcare REIT shares are owned by institutional investors. Comparatively, 33.3% of Life Science REIT shares are owned by institutional investors. 9.3% of Impact Healthcare REIT shares are owned by insiders. Comparatively, 0.0% of Life Science REIT shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Life Science REIT has a consensus price target of GBX 57, suggesting a potential upside of 42.88%. Given Life Science REIT's stronger consensus rating and higher possible upside, analysts clearly believe Life Science REIT is more favorable than Impact Healthcare REIT.
Impact Healthcare REIT pays an annual dividend of GBX 7 per share. Life Science REIT pays an annual dividend of GBX 0.02 per share and has a dividend yield of 0.1%. Impact Healthcare REIT pays out 6,363.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Life Science REIT pays out -50.0% of its earnings in the form of a dividend. Life Science REIT is clearly the better dividend stock, given its higher yield and lower payout ratio.
Summary
Impact Healthcare REIT beats Life Science REIT on 10 of the 16 factors compared between the two stocks.
Get Life Science REIT News Delivered to You Automatically
Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding LABS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Life Science REIT Competitors List
Related Companies and Tools
This page (LON:LABS) was last updated on 9/16/2025 by MarketBeat.com Staff
Free LABS Stock Alerts